ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements
Johnson Pharmacare Limited has approved the shifting of its registered office within the local limits of Ahmedabad. This administrative change was approved at their board meeting.
Johnson Pharmacare Limited has scheduled a board meeting on August 13, 2026, to consider and approve the standalone unaudited financial results for the quarter ending June 30, 2026.
Johnson Pharmacare Ltd has submitted its quarterly shareholding pattern filing for the period ending June 30, 2026, as required by regulatory norms.
Company Secretary Neha Srivastava resigned from the board effective June 11, 2026. The board acknowledges the change with no other material impact.
Johnson Pharmacare filed its Annual Secretarial Compliance Report for FY2026. The report notes non-compliances regarding SDD maintenance and the appointment of internal auditors and a CFO.
Johnson Pharmacare reported audited financial results for the year ended March 31, 2026. The company faces a ₹21.40 Crore debt burden and auditor qualifications regarding internal controls.
Johnson Pharmacare Limited reported annual total income of ₹1.58 Crore for FY 2025-26. The company also announced resignations of directors Rajendra Prasad and Umesh Kumar.
Johnson Pharmacare scheduled a board meeting for May 27, 2026, to approve annual audited financial results. The trading window remains closed until 48 hours post-declaration.
Johnson Pharmacare Ltd confirmed its status as a non-large corporate for FY 2025-26. The company reported zero debt-raising requirements under SEBI's large entity framework.
Johnson Pharmacare Limited confirmed it does not fall under the 'Large Corporate' category for FY 2025-26 per SEBI debt securities framework. The company reported zero outstanding borrowings as of March 31, 2026. This regulatory filing clarifies the company's borrowing status and compliance with SEBI debt-raising norms.
Johnson Pharmacare Limited announced the resignations of Mr. Rajender Parsad (Non-Executive Director) and Mr. Umesh Kumar (Executive Director), effective April 17, 2026. Both directors cited personal reasons for their departures. The board took note of these changes during its meeting held on the same day.
Johnson Pharmacare Ltd has appointed Mr. Nand Kishore Ray as an Additional Non-Executive & Non-Independent Director and Mr. Dheeraj Kumar as an Additional Executive Director, effective April 17, 2026. These appointments were approved during a Board of Directors meeting to strengthen the company's leadership team.
Johnson Pharmacare Limited announced a board reorganization effective April 17, 2026. The company appointed Mr. Nand Kishore Ray and Mr. Dheeraj Kumar as Additional Directors. Simultaneously, Mr. Rajender Parsad and Mr. Umesh Kumar resigned from their respective directorships due to personal reasons. These changes represent a significant update to the company's senior leadership.